Swarajya
Our View
Headlines
Magazine
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Podcasts
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Podcasts
Archives
Blogs
News Brief
BioNTech
Pfizer COVID-19 Vaccine Produces Less Antibodies Against Delta Variant Of Coronavirus, Finds Study Published In Lancet
IANS
Jun 4, 2021 02:38 PM +05:30 IST
German Company BioNTech To Build First mRNA Manufacturing Facility In Singapore
IANS
May 10, 2021 04:25 PM +05:30 IST
Pfizer To Supply Its Covid-19 Vaccine Only Through Government Channels In India: Report
Swarajya Staff
Apr 22, 2021 09:43 AM +05:30 IST
Pfizer-BioNTech Covid-19 Vaccine Effective Against Highly Infectious Coronavirus Variant Discovered In UK, Finds Study
Swarajya Staff
Jan 21, 2021 12:16 PM +05:30 IST
First Adverse Reaction Of Pfizer & BioNTech's COVID-19 Vaccine Recorded In Finland
Swarajya Staff
Jan 3, 2021 02:36 PM +05:30 IST
'Covid-19 Virus Will Stay With Us For Next Ten Years': BioNTech CEO
IANS
Dec 26, 2020 01:41 PM +05:30 IST
Covid Vaccine 'Highly Likely' To Work On UK Variant, Can Adapt It In 6 Weeks To Tackle New Strain If Needed: BioNTech CEO
Swarajya Staff
Dec 22, 2020 06:13 PM +05:30 IST
Pfizer And BioNTech SE To Seek Emergency Use Approval From US FDA For Covid-19 Vaccine
Swarajya Staff
Nov 20, 2020 06:42 PM +05:30 IST
Covid-19 Vaccine Developed By Pfizer-BioNTech Offers 90 Per Cent Protection Against Coronavirus Infection
Swarajya Staff
Nov 9, 2020 06:17 PM +05:30 IST
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
Swarajya Staff
Sep 13, 2020 05:17 PM +05:30 IST
A Tale Of Three Potential Vaccines – How They Stack Up In The Race For Coronavirus Prevention
Karan Kamble
Jul 24, 2020 12:49 PM +05:30 IST
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
Swarajya Staff
Jul 22, 2020 05:55 PM +05:30 IST
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
IANS
May 30, 2020 01:06 PM +05:30 IST
Load More